CGN Nuclear Technology Development Co., Ltd. (SZSE: 000881)
Materials · Chemicals · CN
CN¥6.40
-1.23% today · -20.4% 1Y
CGN Nuclear Technology Development Co., Ltd. (SZSE: 000881) operates in the Chemicals industry within the Materials sector. The company is valued at $902.04M and employs 4,227 people.
Over the last twelve months the share price has lost 20.4%, trading between 6.00 and 9.69.
Tweenvest scores CGN Nuclear Technology Development Co., Ltd. across four factors: quality 43/100, value 49/100, growth 0/100. Its strongest factor is value.
000881 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $902.04M
- Revenue (TTM)
- $811.23M
- P/E
- —
- EPS
- -0.33
- Dividend yield
- —
- Beta (5Y)
- 0.44
- 52-week high
- CN¥9.69
- 52-week low
- CN¥6.00
- Avg volume (3M)
- —
- Shares outstanding
- 945.43M
- Employees
- 4,227
- Next earnings
- —
About CGN Nuclear Technology Development Co., Ltd.
CGN Nuclear Technology Development Co., Ltd. manufactures and sells cable materials and industrial electron accelerators in China. It provides ground nanoaccelerators, electronic curtain accelerators, DG resonant transformer accelerators, and industrial flaw detection accelerators. The company is also involved in the provision of electron beam treatment of specialty waste; antibiotic residue treatment technology; pharmaceutical wastewater treatment technology; medical sewage and solid waste disposal; park sewage treatment; printing and dyeing wastewater treatment technology; coal chemical coking wastewater treatment technology; chemical wastewater treatment technology; domestic sewage treatment technology; and hazardous waste concentrate treatment services. In addition, it provides new energy, irradiated, elastomer, and synthetic materials; modified polycarbonate and polyester, modified polypropylene, continuous fiber reinforced thermoplastic composites, and melt blown and radiation resistant polypropylene; and proton therapy tumor system equipment, raw materials and parts, radioactive medical isotopes, and hospital and nuclear drug products. Further, the company engages in production and sale of plastic; and real estate development, as well as contracting, irradiation processing, ocean shipping, maritime cargo transportation, ship investment and chartering, fishery, and project construction businesses. The company was formerly known as China Dalian International Cooperation (Group) Holdings Ltd. and changed its name to CGN Nuclear Technology Development Co., Ltd. in February 2017. CGN Nuclear Technology Development Co., Ltd. was founded in 1993 and is based in Shenzhen, China.
- ISIN
- CNE000000842
- Founded
- 1993
- Listed since
- Sep 2, 1998
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Neo Performance Materials Inc.TSX: NEO | $907.37M | CA$27.91 | -8.46% |
| Liaoning Xinde New Material Technology Co., Ltd.SZSE: 301349 | $906.53M | CN¥42.90 | -7.04% |
| Ningbo Exciton Technology Co., Ltd.SZSE: 300566 | $905.64M | CN¥23.39 | -10.52% |
| China Risun Group LimitedSEHK: 1907 | $902.23M | HK$1.67 | +3.10% |
| Kronos Worldwide, Inc.NYSE: KRO | $900.06M | $7.82 | +0.51% |
| Gujarat Narmada Valley Fertilizers & Chemicals LimitedNSEI: GNFC | $899.14M | Rs589.15 | -6.53% |
| Sichuan Lutianhua Company Limited By SharesSZSE: 000912 | $893.33M | CN¥3.88 | -1.27% |
| Clean Science and Technology LimitedNSEI: CLEAN | $886.47M | Rs803.05 | -0.52% |
Figures last refreshed Oct 4, 2026.